- If the disease breaks out all over his skin and,
so far as the Priest can see, it covers all the skin
of the infected person from head to foot,
the Priest is to examine him, and if the disease
has covered his whole body,
he shall pronounce that person clean.
Since it has all turned white he is clean.
-Leviticus 13:12-13, New International Version
Selected Dallas/Fort Worth Psoriasis Support Group Meeting Data/History:
9-24-03 Meeting agenda from initial group meeting on 9-24-03.
11-12-03 An Integrative Approach for the Treatment of Psoriasis - Dennis Song, Rph
This document contains notes from Dennis Song's presentation. Dennis Song is the owner of Flower
Mound Herbal Pharmacy. The Pharmacy telephone number is (972) 355-4614 and Dennis' email is:
fmherbalrx@aol.com. Thanks to Dennis Song and Flower Mound Herbal Pharmacy for a great presentation!
12-10-03 New Treatments for Psoriasis and Psoriatic Arthritis - Kristine Kucera, PA-C, MPAS
This document contains notes from Kristine Kucera's presentation. Kristine works out of the Dermatology
office of Dr. S. Robert Harla in Grapevine. The telephone number for Dr. Harla's office is (817) 329-2263.
This meeting was sponsored by AMGEN. AMGEN is the manufacturer of the Psoriasis and Psoriatic
Arthritis drug Enbrel. Thanks again to AMGEN and Connie Zeigler for sponsoring our meeting and thanks to
Kristine for a great presentation!
1-14-04 Meeting Minutes from 1-14-04 meeting.
2-11-04 Meeting Minutes from 2-11-04 meeting.
3-10-04 Meeting Minutes from 3-10-04 meeting.
4-14-04 Meeting Minutes from 4-14-04 meeting. Includes the presentation - Psoriasis and Psoriatic
Arthritis: An Update, by Melodie Young, MSN, RN, ANP-C, Nurse Practitioner, Texas Dermatology Psoriasis
Clinic, Dallas, TX (Dr. Alan Menter's Office). The telephone number for Texas Dermatology Psoriasis Clinic
is (972) 386-7546. This meeting was sponsored by Genentech, Inc. - Stacie Kopp and Stephen Merrill,
Dallas/Fort Worth area representatives for Genentech. Genentech is the manufacturer of the psoriasis
drug Raptiva. Thanks to Melodie for an excellent presentation and to Genentech and Stacie and Stephen for
the sponsorship.
5-12-04 Meeting Presentation by David Gibson of AMGEN
This meeting was sponsored by AMGEN, makers and distributors of Enbrel. This presentation provides
some excellent information on psoriasis and psoriatic arthritis and an in-depth discussion of the role of TNF
in Psoriasis. Thanks to David Adams and David Gibson of AMGEN for sponsoring this meeting and for the
excellent presentation. Group members also screened the movie "The Singing Detective" at this meeting.
NOTE: The above presentation is a rather large file with a lot of graphics. It is recommended that you save
the file to your computer as opposed to trying to view it on-line.
6-9-04 Meeting Minutes from 6-9-04 meeting.
7-14-04 Meeting Presentation by Christina Carrigan of UT Southwestern
Meeting Presentation topic was "Information on Clinical Trials." Christina Carrigan, R.N.
Senior Research Nurse, Department of Dermatology, University of Texas Southwestern Medical Center,
Phone (214) 648-1390
2-9-05 Meeting Presentation by Deirdre Earls, Registered Dietician/Nutritionist, "Let Food be
your Medicine." (Lewisville Meeting site)
Picture 01 from 2/9/05 meeting
Picture 02 from 2/9/05 meeting
4-7-05 Meeting Presentation by Dr. Angela Moore, MD, "Let's Talk Psoriasis."
5-5-05 Meeting Presentation by Deirdre Earls, Registered Dietician/Nutritionist, "Let Food be
your Medicine." (Arlington Meeting Site)
Picture from 5/5/05 Meeting
9-1-05 Meeting Presentation by David Bruce - "Being a Powerful Patient."
This document is from a presentation given by David at the National Psoriasis Foundation's Annual
Conference in Boston in August 2005
2-06 Phototherapy - Presentation by Dr. Angela Moore, MD of Arlington Center for Dermatology
3-06 Conception, Pregnancy and Psoriasis - Presentation by Dr. Angela Moore, MD of Arlington Center
for Dermatology
4-06 Treating Specific Skin Sites - Presentation by Dr. Angela Moore, MD of Arlington Center for
Dermatology
9-06 Topical Treatments for Psoriasis - Presentation by Dr. Angela Moore, MD of Arlington Center for
Dermatology
11-8-06 New Biologic Therapy for Psoriasis and Psoriatic Arthritis - This meeting held at the offices of
Modern Dermatology in Dallas. Presentation by Dr. Jennifer Cather and Melodie Young, PA. Meeting
sponsored by Centocor, Inc., makers of the biologic drug Remicade.
12-5-06 New Biologic Therapy for Psoriasis and Psoriatic Arthritis - This meeting held at the offices of
Dr. Kent Aftergut, M.D. Charlton Methodist Hospital, 3500 W. Wheatland Road, Meeting Room #7, Dallas, TX
75237, Phone: (214) 947-7777. Meeting sponsored by Centocor, Inc., makers of the biologic drug
Remicade.
12-6-06 New Biologic Therapy for Psoriasis and Psoriatic Arthritis - Speaker was David R. Hensley, M.D.
This meeting held at the offices of Mullanax Dermatology, 715 N. Fielder Road, Arlington, TX 76012, Phone:
(817) 261-1626. Meeting sponsored by Centocor, Inc., makers of the biologic drug Remicade.
4-14-07 "Innerstate" Film Premiere at AMC Grand 24 at 10110 Technology Blvd. East, Dallas, TX 75220
5-19-07 "Psoriasis More Than "Skin Deep" program at the Hotel Palomar in Dallas. Speakers were
Jennifer Cather, M.D. and Melodie Young, M.S.N., R.N., A.N.P.
Dallas/Fort Worth Psoriasis Support Group Documents:
1-25-04 Support Group Meeting Flyer
1-25-04 Support Group Mission Statement
8-8-05 Shared Destinations: Being Active With Support Groups
This document is from a presentation given by David Bruce at the National Psoriasis Foundation's
Annual Conference in Boston in August 2005
National Psoriasis Foundation Documents:
11-14-03 Foundation Volunteer Opportunities
11-14-03 Foundation Volunteer Application Form
11-14-03 Community Outreach Volunteer
11-14-03 Medical Outreach Volunteer
11-14-03 School Outreach Volunteer
1-29-04 Foundation Legislative Agenda 2004
Research Articles:
10-23-03 Raptiva FDA Approval
11-9-03 Three genes linked to psoriasis susceptibility identified on chromosome 17
11-15-03 Advancing the Cause of Research - What you need to know about a clinical trial
12-29-03 CytoGenix Scientists Discover Bacterial Gene Silencing Technology
1-5-04 Biotechnology Industry Posts FDA Approvals
1-6-04 Kudzu: Vine That Ate the South Takes Bite Out of Tri-State
1-9-04 Immune-Mediated Diseases & Inflammation Drug Discovery World Summit
1-13-04 New Phototherapy Technology Developed in Israel
1-15-04 Astralis receives patent for treatment of psoriasis
1-27-04 Advance PCS Signs Agreement to Distribute Raptiva
1-29-04 Dermatological Drug Market Races Toward $10 Billion
2-12-04 Abbott Laboratories Announces Positive Results of Phase II HUMIRA(R)
2-12-04 Syngenta steps up drugs-from-plants investment
2-12-04 Promising Results Presented for REMICADE(R) (Infliximab) in the Treatment
2-12-04 Survey Shows Impact of Psoriasis Is More Than Skin Deep
2-17-04 Chat Rooms Buzz About AuraSoothe
2-24-04 Astralis Files New Patents for Psoriasis Medications
2-25-04 FDA Agrees to Clinical Development Plans for ISA247
2-26-04 Unique Fiber-optic Hairbrush System for Scalp Psoriasis Now Available
3-8-04 Connetics Completes Soriatane Acquisition
3-29-04 Astralis Initiates U.S. Phase II Clinical Trial for Psoraxine for Psoriasis
3-29-04 New Study Finds Even a 'Small' Amount of Psoriasis can impact life
3-30-04 SkyePharma's Partner Astralis Initiates US Phase II Trial for Psoriasis
3-31-04 Positive arthritis drug data boost UK's Celltech
4-14-04 Britney, Ben and J. Lo, and more from Sundance
4-14-04 Regence Group Adopts Reimbursement for PhotoMedex XTRAC(R)
4-29-04 Psoriasis Medications Can Treat More Than the Skin
4-29-04 Patients Show Improvement in Phase II Psoriasis Study of Novel Oral
4-29-04 Isotechnika to Test Drug Solo As Roche Steps Aside
4-30-04 FDA Approves ENBREL to Treat Psoriasis
5-17-04 National Psoriasis Foundation Releases 2004 Legislative Agenda, Visits
5-26-04 Catwalk Beauty Vendela to Help Educate Public About Effects of Psoriasis
5-26-04 Aetna Adopts Reimbursement for PhotoMedex XTRAC(R)
6-23-04 New Two-Year Data Demonstrate That ENBREL Therapy Allowed Significantly
6-23-04 REMICADE(R) Psoriatic Arthritis Clinical Trial Demonstrates New Level of Benefit
6-23-04 Preliminary Data From Two Clinical Trials Demonstrate Abbott Laboratories'
7-29-04 Science Targets Cause of Psoriasis Before It Starts Dermatologists Find New
7-29-04 Serono-Raptiva safe, efficient in long-term study
7-29-04 Preliminary Data Showed Sustained Clinical Benefit with Raptiva
7-29-04 Senior U.S. Doctor Issues Statement on Safety and Efficacy of Neuroskin
7-29-04 New Survey Finds People With Psoriasis Worry About Getting Up Close
7-29-04 Skin Damage from Sun Rare with Psoriasis
7-29-04 Galderma Launches CLOBEX(TM) Shampoo for Scalp Psoriasis for Adults
8-3-04 Wyeth says EU panel recommends Enbrel approval
8-3-04 TolerRx Initiates Clinical Trial of TRX4 for Psoriasis
8-3-04 National Psoriasis Foundation Issues Psoriasis Awareness Month Call
8-9-04 Abbott Study Shows Psoriasis Relief
8-9-04 Astralis Presents US Phase I Results for Novel Psoriasis Treatment
8-11-04 Prevention Magazine Article on TNF Related to Trans-Fat in the Diet
8-30-04 FDA Says Remicade Users Suffer Ailments
8-30-04 Targretin Shows Promise Against Psoriasis
9-2-04 MedImmune Discontinues Rheumatoid Arthritis and Psoriasis Trials for Vitaxin(R)
9-2-04 Dermatology Drug Market Will Experience Modest Growth of 8% Through 2008
9-2-04 Advitech Announces Promising Results From Open Clinical Study On New Oral
9-28-04 Coping Without Vioxx - Recall of Merck's Pain Drug Sparks Hunt for Alternatives
9-28-04 Anthem Adopts Reimbursement for PhotoMedex XTRAC(R)
9-30-04 Increased Diagnosis Spur U.S. Autoimmune Disorders Markets for Biologics
10-3-04 Psoriasis Drug Market Will Grow Substantially, Reaching $3.3 Billion in 2013
10-6-04 FDA Approves New and Easy Way to Take ENBREL
10-6-04 Amgen's Enbrel gets label extension from FDA
10-21-04 Abbott's Humira Shows Promise In Phase III Studies
10-22-04 Pfizer Warns of Risks From Its Painkiller Bextra
10-22-04 J&J says Remicade effective in psoriatic arthritis
10-28-04 1st World Psoriasis Day, 29 October 2004: New International Survey Shows
11-9-04 BioCryst Pharmaceuticals Initiates Clinical Development of BCX-4208
2-1-05 Advitech to Present Study Findings on XP-828L
2-1-05 New Psoriasis and Eczema Treatment Receives U.S. Patent
2-12-05 The Psychological and Social Burdens of Psoriasis
2-12-05 Asthma, Allergies, Psoriasis During Pregnancy Linked to Increased
2-12-05 New Study Finds Psoriasis Twice as Common Among African-Americans
2-12-05 Raymond's Ointment Recipe
2-14-05 Arthritis Drug Methotrexate Seen to Cut Heart Risk
2-14-05 Advitech Completes Recruitment for Its Second Clinical Study
2-14-05 Medicis: FDA Approves NDA For Psoriasis Treatment, Vanos
2-17-05 Cell transplants aid diabetics (Enbrel used in process)
2-18-05 Psoriasis Advocacy Group, Speaking at FDA hearing, Urges FDA Not to slow approval
2-18-05 New Humira Data Shows Improvement In Disease Activity And Quality Of Life
2-21-05 Genentech psoriasis drug Raptiva effective long term-study
2-21-05 Biologic Advances in the Treatment of Psoriasis
2-21-05 Cancer Warning Suggested for Eczema Creams (Protopic)
4-11-05 National Psoriasis Foundation Rallies in Washington to Gain Legislative Support
4-18-05 Bit of stress good for immune system, under certain conditions
4-21-05 Tumor Necrosis Factor Alpha Inhibitors for The Treatment of Dermatologic
4-21-05 Genizon Biosciences Announces Major Milestone in Identifying Psoriasis Genes
4-21-05 Safety has role in psoriasis drug choice
5-10-05 Local Docs Explore Arthritis, Psoriasis Link
5-10-05 Psoriasis Foundation Grant Goes to Oregon Researcher
5-10-05 Abdul says odd behavior not drug-related
6-28-05 Amgen/Wyeth's Enbrel Leads the Market for Biologic Therapies to Treat
6-28-05 Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion for Treatment of Psoriatic
6-29-05 Long-Term REMICADE Data Demonstrate Sustained Efficacy in Treatment of Active
7-4-05 Ointment May Soothe Psoriasis
7-4-05 Data Shows ENBREL Gave Psoriasis Patients Benefit After Dose Cut
7-5-05 Dancer on trial for hiding Peru rebel chief
7-7-05 Advitech announces positive results of XP-828L study in psoriasis
7-8-05 PhotoMedex XTRAC(R) Receives Favorable Policy Decision from UnitedHealthcare
7-10-05 Why good cells go bad in progression of MS
7-15-05 The Skinny on Psoriasis
9-8-05 Psoriasis Urges FDA Panel to Approve Abatacept for Rheumatoid Arthritis
9-8-05 IBD Linked to Risk of Multiple Sclerosis
9-9-05 Risk Free Treatment for Chronic Psoriatic Patients Found
9-12-05 Biogen Idec Cuts 17% of Jobs
9-12-05 Biogen and Amevive
9-19-05 FDA approves Remicade as first biologic to treat ulcerative colitis
9-20-05 Celera Genomics Initiates Trial for Cathepsin Inhibitor for Treatment of Psoriasis
10-3-05 "My Skin's On Fire"
10-3-05 Inflammatory bowel disease increases risk of other serious disorders
10-4-05 Abbott Gets Expanded Humira Approval
10-11-05 Starve death home 'understaffed'
10-13-05 Long Term Benefit of Continuous Treatment with Raptiva
10-18-05 Arthritis drug Remicade effective against psoriasis
10-31-05 Genetic link between heart disease and psoriasis
10-31-05 Galderma Receives FDA Approval for CLOBEX(R) Spray for Plaque Psoriasis
12-8-05 Life with psoriasis
12-8-05 Celiac Disease Antibodies Correlate with Psoriasis Activity
12-8-05 Notes on Psoriasis and Celiac Disease
12-8-05 A connection between psoriasis and celiac disease suspected for some
( From the National Psoriasis Foundation's Advance Magazine July/Aug 2004)
12-8-05 Management of Celiac Disease
(Originally Published Aug. 2003)
12-12-05 Nutrients for the skin
12-14-05 Psoriasis Drug May Also Fight Depression
1-02-06 Smoking tied to more severe psoriasis cases: study
1-06-06 British Journal of Dermatology - Diet and Psoriasis
(Contains a large section on Celiac Disease)
1-06-06 Coeliac (Celiac) disease: the great imitator
1-06-06 Interpretation of Celiac Disease Blood Test Results
1-06-06 10 Facts about Celiac Disease
1-06-06 Medicare expands tier pricing system-Cancer, arthritis, MS drugs fall in highest levels
1-10-06 National Psoriasis Foundation to Speak Out on Capitol Hill
1-12-06 Trigger for Common Skin Disease Found
1-12-06 Advitech psoriasis product to reach US market
4-10-06 Astellas to acquire Biogen's psoriasis treatment
4-10-06 Scientists Spot Psoriasis Gene
4-10-06 Drug May Fight Metabolic Syndrome
4-25-06 Genetic finding suggests alternative treatment strategy for common, complex skin
9-23-06 Allergy cells can aggravate cancer and psoriasis
9-27-06 FDA Approves REMICADE(R) for Treatment of Chronic Severe Plaque Psoriasis
9-30-06 Calgenex Introduces New Topical Psoriasis Treatment
10-5-06 Humira Proves Effective in Treatment of Psoriasis
10-7-06 New Data Reinforce Safety Profile Of ENBREL (Etanercept)
10-9-06 Severe Psoriasis Linked to Heart Attacks
10-17-06 National Psoriasis Foundation Announces Results Of Attitudes Toward Psoriasis Survey
10-19-06 Topical treatment for psoriasis, eliminates need for injections
10-26-06 World Psoriasis Day Calls Attention to a Serious Disease
10-26-06 Psoriasis: Skin Symptoms may be Just the tip of the Iceberg
10-27-06 Gene Could Point to Crohn's, Colitis Treatments
10-27-06 World Psoriasis Day promotes greater understanding of the disease in Singapore
10-31-06 Psoriasis support group on the way (Bahrain)
10-31-06 Psoriasis Fact Sheet
11-13-06 Bioenvision Files to Start Trial of Clofarabine Gel for Psoriasis
11-13-06 ENBREL is First Biologic to Show Safety/Sustained Efficacy for Up to 9 Years
11-13-06 Cancer risk from arthritis drugs overstated-study
11-14-06 Humira Gets Expanded Approval for Psoriatic Arthritis
11-15-06 Evidence of psoriasis and heart disease link is revealed
4-7-07 Congress said to want cheaper biotech drugs
4-18-07 Psoriasis Linked To Diabetes And Serious Cardiovascular Condition
5-7-07 Questions remain on risk of tanning
5-2-07 National Psoriasis Foundation Signs CariDee English as Spokesperson
5-7-07 Jury still out on gluten, the latest dietary villain
5-8-07 Priced out of pain relief
5-8-07 Malabsorption in psoriatic patients: cause or consequence?
5-8-07 Psoriasis patients at higher risk for celiac disease
5-22-07 Celgene Gains on Psoriasis Drug Results
5-25-07 New insights into chronic inflammation and atherosclerosis
Resources
| Dallas/Fort Worth Psoriasis and Psoriatic Arthritis Support Group |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
SEARCH THIS SITE